Lukas Kazianka

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Christoph Kornauth, Tea Pemovska, Gregory I. Vladimer et al. · Cancer Discovery · 2021 · 207 citations · Full text

Medicine, Hematology, Oncology +12

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study

Berend Snijder, Gregory I. Vladimer, Nikolaus Krall et al. · The Lancet Haematology · 2017 · 182 citations · Full text

Medicine, Oncology, Pharmacology +15

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Bernd Boidol, Christoph Kornauth, Emiel van der Kouwe et al. · Blood · 2017 · 72 citations

Medicine, Hematology, Oncology +13

CXCR4 PET imaging of mantle cell lymphoma using [⁶⁸Ga]Pentixafor: comparison with [¹⁸F]FDG-PET

Marius E. Mayerhoefer, Markus Raderer, Wolfgang Lamm et al. · Theranostics · 2020 · 64 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib

Lukas Kazianka, Christa Drucker, Cathrin Skrabs et al. · Leukemia · 2016 · 39 citations · Full text

Medicine, Hematology, Pharmacology +17